Search
for

    Sort by

    Research 30 of 1000+

    1. Approach to the Patient: Diagnostic Challenges in the Work Up for Polycystic Ovary Syndrome The Journal of Clinical Endocrinology & Metabolism · 2025
    2. Serum AMH levels in the differential diagnosis of hyperandrogenemic conditions European Journal of Obstetrics & Gynecology and Reproductive Biology · 2014 · 9 citations
    3. Secondary Amenorrhea and Clinical Hyperandrogenism in a 34-Year-Old Female: Polycystic Ovary Syndrome or Not? Clinical Chemistry · 2025
    4. Serum anti-Müllerian hormone as a predictor of polycystic ovarian syndrome among women of reproductive age BMC Women's Health · 2022 · 4 citations
    5. Serum Anti-Müllerian Hormone as a Predictor of Polycystic Ovarian Syndrome among Women of Reproductive Age Research Square (Research Square) · 2022
    6. Anti Mullerian Hormone: A Potential Marker for Recruited Non Growing Follicle of Ovarian Pool in Women with Polycystic Ovarian Syndrome Journal of Clinical and Diagnostic Research · 2013 · 6 citations
    7. Anti-Müllerian Hormone and Polycystic Ovary Syndrome in Women and Its Male Equivalent Biomedicines · 2022 · 18 citations
    8. Diagnostic utility of serum anti-Müllerian hormone in different phenotypes of polycystic ovary syndrome: a case-control study from a tertiary care centre International Journal of Reproduction Contraception Obstetrics and Gynecology · 2026
    9. Serum phoenixin-14 and phoenixin-20 concentrations in polycystic ovary syndrome: Associations with anti-Müllerian hormone and diagnostic utility Biomolecules and Biomedicine · 2026
    10. Adrenal and Gonadal Activity, Androgen Concentrations, and Adult Height Outcomes in Boys With Silver-Russell Syndrome Frontiers in endocrinology · 2019 · 1 citations
    11. Concurrent autoimmune and endocrine dysregulation in polycystic ovary syndrome Middle East Fertility Society Journal · 2025 · 1 citations
    12. Hallmark evidence of lipopolysaccharide (LPS) tolerance in obese women with polycystic ovary syndrome (PCOS) - LPS-induced NFkB suppression in mononuclear cells (MNC) is linked to hyperandrogenism in PCOS Fertility and Sterility · 2018
    13. Phenotypic Characterization of Patients with Polycystic Ovary Syndrome in a Population from the Ecuadorian Andes: A Cross-Sectional Study Journal of clinical medicine · 2024
    14. Hormonal Profile and Anthropometric Indices As Determinants of Metabolic Risk in Polycystic Ovary Syndrome: A Prospective Observational Study Cureus · 2026
    15. Canine Sertoli cell tumor: anti-Müllerian hormone, inhibin B, and estrone sulphate Clinical theriogenology · 2023
    16. In Search of New Therapeutics—Molecular Aspects of the PCOS Pathophysiology: Genetics, Hormones, Metabolism and Beyond International Journal of Molecular Sciences · 2020 · 44 citations
    17. Metabolic Syndrome and Insulin Resistance Syndrome among Infertile Women with Polycystic Ovary Syndrome: A Cross-Sectional Study from Central Vietnam Endocrinology and Metabolism · 2018 · 14 citations
    18. Anti-Müllerian hormone confirms the novel classification of female functional androgenization including polycystic ovary syndrome European Journal of Endocrinology · 2011 · 12 citations
    19. MC4R variants rs12970134 and rs17782313 are associated with obese polycystic ovary syndrome patients in the Western region of Saudi Arabia BMC Medical Genetics · 2019 · 12 citations
    20. Curtailing PCOS Pediatric Research · 2019 · 43 citations
    21. May AMH levels distinguish LOCAH from PCOS among hirsute women? European Journal of Obstetrics & Gynecology and Reproductive Biology · 2014 · 5 citations
    22. Resistance to the Insulin and Elevated Level of Androgen: A Major Cause of Polycystic Ovary Syndrome Frontiers in Endocrinology · 2021 · 36 citations
    23. Regenerative Effect of Intraovarian Injection of Activated Autologous Platelet Rich Plasma: Serum Anti-Mullerian Hormone Levels Measured Among Poor-Prognosis In Vitro Fertilization Patients International Journal of Regenerative Medicine · 2020 · 31 citations
    24. Elevated fasting insulin is associated with cardiovascular and metabolic risk in women with polycystic ovary syndrome Diabetes and Metabolic Syndrome: Clinical Research and Reviews · 2019 · 17 citations
    25. How to Choose the Optimal Starting Dose of Clomiphene Citrate (50 or 100 mg per Day) for a First Cycle of Ovulation Induction in Anovulatory PCOS Women? Journal of Clinical Medicine · 2023
    26. Is there association between thyroid stimulating hormone levels and the four phenotypes in polycystic ovary syndrome? Ginekologia Polska · 2022 · 15 citations
    27. A Model for Predicting Polycystic Ovary Syndrome Using Serum AMH, Menstrual Cycle Length, Body Mass Index and Serum Androstenedione in Chinese Reproductive Aged Population: A Retrospective Cohort Study Frontiers in Endocrinology · 2022 · 5 citations
    28. Accuracy of anti-Müllerian hormone and total follicles count to diagnose polycystic ovary syndrome in reproductive women Taiwanese Journal of Obstetrics & Gynecology · 2018 · 13 citations
    29. Abstract 152 Indian Journal of Endocrinology and Metabolism · 2022
    30. Impact of subclinical hypothyroidism on endocrine features in patients with polycystic ovary syndrome European journal of medical research · 2025 · 1 citations